Your influence matters: Recommending cancer screenings to your patients

Patients say they are more likely to have a cancer screening when their physician recommends it. What else can you do to influence cancer screenings?¹

• Understand the power of the physician recommendation.
  • Your recommendation is the most influential factor in whether a person decides to get screened.
  • Patients are 90% more likely to get a screening when they reported a physician recommendation.
  • “My doctor did not recommend it,” is the primary reason for screening avoidance.
• Recognize cultural barriers that may impact your diverse patients.
• Culturally sensitive conversations with your patients can help with fear, embarrassment, anxiety, and misconceptions about screenings.
• Go to mydiversepatients.com for information and resources.
• Measure the screening rates in your practice; it may not be as high as you think.
  • Set goals to get screening rates up.
  • Follow the HEDIS® guidelines included in this article to help accurately track your care gap closures.
• More screening doesn’t have to mean more work for you.
  • Reach out to us about available member data – we may be able to help identify or supply access to data for those members who are due screenings.
  • Develop a reminder system, which has been demonstrated to be effective, to remind you and staff that patients have screenings due.
• Help members access benefit information about screenings to eliminate the cost barrier.
  • Log onto Availity.com and use the Patient Information tab to run an Eligibility and Benefits inquiry.
  • Members can access their benefit information by logging onto anthem.com, through Live Chat, or by downloading the Sydney Health App.
  • Blue Cross Blue Shield Service Benefit Plan members, also known as Federal Employee Program® members, can access their benefit information by logging onto fepblue.org, or by downloading the fepblue App from the Apple Store or on Google Play.

 

Measure Up: Cancer Screening for Women HEDIS® Measure Specifications

Organized and continuous screenings along with removal of precancerous lesions can lead to a 60% decrease in cervical cancer.²

 

Cervical Cancer Screening (CCS) is measured by the percentage of women 21 to 64 years of age who were screened for cervical cancer using either of the following criteria:

• Women 21–64 years of age who had cervical cytology performed within the last 3 years.
• Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
• Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) co-testing within the last 5 years.

 

Description	Code
Cervical cytology lab test	CPT: 88141-88143, 88147, 88148, 88150, 88152-88153, 88164-88167, 88174, 88175 HCPCS: G0123, G0124, G0141, G0143-G0145, G0147, G0148, P3000, P3001, Q0091 LOINC: 10524-7, 18500-9, 19762-4, 19764-0, 19765-7, 19766-5, 19774-9, 33717-0, 47527-7, 47528-5
hrHPV lab test	CPT: 87620-87622, 87624-87625 HCPCS: G0476 LOINC: 21440-3, 30167-1, 38372-9, 59263-4, 59264-2, 59420-0, 69002-4, 71431-1, 75694-0, 77379-6, 77399-4, 77400-0, 82354-2, 82456-5, 82675-0
Absence of cervix diagnosis	ICD-10-CM: Q51.5, Z90.710, Z90.712
Hysterectomy with no residual cervix	CPT: 51925, 56308, 57530, 57531, 57540, 57545, 57550, 57555, 57556, 58150, 58152, 58200, 58210, 58240, 58260, 58262, 58263, 58267, 58270, 58275, 58280, 58285, 58290-58294, 58548, 58550, 58552-58554, 58570-58573, 58575, 58951, 58953, 58954, 58956, 59135 ICD-10-PCS: 0UTC0ZZ, 0UTC4ZZ, 0UTC7ZZ, 0UTC8ZZ

 

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

 

1 http://thecanceryoucanprevent.org/wp-content/uploads/14893-80_2018-PROVIDER-PHYS-4-PAGER-11-10.pdf

2 National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/9253676/

 

819-0322-PN-NE